Back to Search Start Over

Generation of a set of isogenic iPSC lines carrying all APOE genetic variants (Ɛ2/Ɛ3/Ɛ4) and knock-out for the study of APOE biology in health and disease

Authors :
Innovative Medicines Initiative
European Commission
Schmid, B.
Holst, B.
Clausen, C.
Bahnassawy, L.
Reinhardt, P.
Bakker, M.H.M.
Vicario-Abejón, Carlos
Martino-Adami, P.V.
Thoenes, M.
Ramírez, Alfredo
Flissbac, K.
Innovative Medicines Initiative
European Commission
Schmid, B.
Holst, B.
Clausen, C.
Bahnassawy, L.
Reinhardt, P.
Bakker, M.H.M.
Vicario-Abejón, Carlos
Martino-Adami, P.V.
Thoenes, M.
Ramírez, Alfredo
Flissbac, K.
Publication Year :
2021

Abstract

APOE genotype is the strongest genetic risk factor for Alzheimer’s Disease (AD). The low degree of homology between mouse and human APOE is a concerning issue in preclinical models currently used to study the role of this gene in AD pathophysiology. A key objective of ADAPTED (Alzheimer’s Disease Apolipoprotein Pathology for Treatment Elucidation and Development) project was to generate in vitro models that better recapitulate human APOE biology. We describe a new set of induced pluripotent stem cells (iPSC) lines carrying common APOE variants (Ɛ2, Ɛ3, and Ɛ3/Ɛ4) and a knock-out isogenic to the parental APOE Ɛ4/Ɛ4 line (UKBi011-A).

Details

Database :
OAIster
Publication Type :
Electronic Resource
Accession number :
edsoai.on1286581391
Document Type :
Electronic Resource